Walter Reed

Latest Headlines

Latest Headlines

U.S. Army, GSK's P. vivax malaria vaccine fails to protect in early trial

A vaccine developed in collaboration between GlaxoSmithKline and the U.S. Army failed to protect subjects in an early trial against the world's most prevalent malaria parasite. Researchers will press forward, however, saying the knowledge gained may assist future development.

Walter Reed kicks off PhI trial of Inovio's MERS vaccine

Three months after teaming up with the Walter Reed Army Institute of Research, Inovio and GeneOne are kicking off Phase I trials of its MERS vaccine. The biotechs joined forces with Walter Reed in November to conduct Phase I trials, citing the disease as an "emergent global health concern." MERS has killed nearly 600 and infected 1,650 people since it emerged in 2012.

GenVec inks $3.5M deal with Naval Medical Research Center

GenVec inked a $3.5 million agreement with the Naval Medical Research Center to support malaria vaccine development.

USAID, IDRI form malaria vax collaboration

The Infectious Disease Research Institute and United States Agency for International Development have reached a memorandum of understanding to develop a new malaria vaccine in partnership with the